FRI-043-Primary biliary cholangitis-Autoimmune hepatitis overlap syndrome: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort

MLA

Richard C. Zink, et al. “FRI-043-Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome: Characteristics and Response to Obeticholic Acid in TARGET-PBC, a Diverse, Large United States Real-World Cohort.” Journal of Hepatology, vol. 70, Apr. 2019, p. e403. EBSCOhost, https://doi.org/10.1016/s0618-8278(19)30793-5.

APA

Richard C. Zink, Ester C. Little, Cynthia Levy, Elizabeth J. Carey, Robert Sandefur, Marlyn J. Mayo, W. Ray Kim, Karen Deane, & Christopher L. Bowlus. (2019). FRI-043-Primary biliary cholangitis-Autoimmune hepatitis overlap syndrome: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort. Journal of Hepatology, 70, e403. https://doi.org/10.1016/s0618-8278(19)30793-5

Chicago

Richard C. Zink, Ester C. Little, Cynthia Levy, Elizabeth J. Carey, Robert Sandefur, Marlyn J. Mayo, W. Ray Kim, Karen Deane, and Christopher L. Bowlus. 2019. “FRI-043-Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome: Characteristics and Response to Obeticholic Acid in TARGET-PBC, a Diverse, Large United States Real-World Cohort.” Journal of Hepatology 70 (April): e403. doi:10.1016/s0618-8278(19)30793-5.